European markets in mixed territory after a positive start
January 26, 2026
12 Sweet Feminine Aesthetic Outfits for the Summer Season
March 13, 2026
Servier is expanding its neurology focus to include neuromuscular disorders by acquiring a clinical-stage Edgewise Therapeutics drug that offers a ...
Read moreDetailsTriomica startup building an AI-powered platform to help oncologists and administrative staff automate data-intensive tasks such as clinical trial matching ...
Read moreDetailsA Daiichi Sankyo and AstraZeneca drug is now available approved as first-line treatment for a type of breast cancer that ...
Read moreDetailsBiopharmaceutical companies aim to make taking a biologic drug as easy as possible for patients, marketing many of these chronically ...
Read moreDetailsThe IPO window for biotech companies appears to be reopening. Last week ended with three biotech companies hitting the public ...
Read moreDetailsCancer drug research continues to provide patients with targeted therapies for tumors that express specific genetic or biological signatures. This ...
Read moreDetails© © Copyrights 2026 Vidianews. All Rights Reserved. Designed by Vidianews